TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer.

Autor: Tan, Gongxun1 (AUTHOR), Jin, Bingquan2 (AUTHOR), Qian, Xiaoqin3,4 (AUTHOR), Wang, Yuguo5 (AUTHOR), Zhang, Guoliang6 (AUTHOR), Agyekum, Enock Adjei1 (AUTHOR), Wang, Feng7 (AUTHOR), Shi, Liang7 (AUTHOR), Zhang, Yue2 (AUTHOR), Mao, Zhenwei8 (AUTHOR), Shi, Chunhe9 (AUTHOR), Xu, Ying10 (AUTHOR), Li, Xiuying10 (AUTHOR), Zhang, Lele7 (AUTHOR) smilesmilezhang@163.com, Li, Shaohua7 (AUTHOR) shli2013@163.com
Zdroj: Scientific Reports. 10/10/2024, Vol. 14 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje